The UCLA trial is currently enrolling patients.
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's Department of Radiation ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces that the first patient in the United States (U ...
Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...
Colin Egglesfield shared an update after his third cancer diagnosis. The All My Children actor revealed in 2025 that he was ...
Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ReSTART pivotal skin cancer trial as well as trials in cance ...
Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results